4//SEC Filing
Posner Christopher 4
Accession 0001209191-22-013988
CIK 0001346830other
Filed
Feb 28, 7:00 PM ET
Accepted
Mar 1, 4:17 PM ET
Size
7.7 KB
Accession
0001209191-22-013988
Insider Transaction Report
Form 4
Posner Christopher
DirectorPRESIDENT AND CEO
Transactions
- Award
Stock Option (Right to Buy)
2022-02-25+121,000→ 121,000 totalExercise: $10.46Exp: 2032-02-25→ Common Stock (121,000 underlying) - Award
Common Stock
2022-02-25+39,000→ 203,037 total
Footnotes (2)
- [F1]Represents the number of shares underlying restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of common stock of the Issuer. The RSUs vest in three equal annual installments on each of February 25, 2023, February 25, 2024 and February 25, 2025, in each case, subject to the Reporting Person's continued service (as that term is defined in the Issuer's 2014 Equity Incentive Plan) as of each such date.
- [F2]The shares shall vest and become exercisable in a series of 48 successive equal monthly installments beginning on March 25, 2022, in each case subject to the Reporting Person's continued service as of each such date.
Documents
Issuer
Cara Therapeutics, Inc.
CIK 0001346830
Entity typeother
Related Parties
1- filerCIK 0001748265
Filing Metadata
- Form type
- 4
- Filed
- Feb 28, 7:00 PM ET
- Accepted
- Mar 1, 4:17 PM ET
- Size
- 7.7 KB